The role of pressor agents, and particularly serotonin,' in the pathogenesis ofpregnancy induced hypertension has been proposed. Abnormal circulating concentrations ofserotonin have not been detected,2 but serotonin concentrations in platelets of pre-eclamptic women are reduced.3 A recent report of the successful treatment of an eclamptic patient with widespread cerebral ischaemia with nimodipine,4 a potential inhibitor of serotonin, promised further study. Twenty four hour specimens of urine from patients with pregnancy induced hypertension and controls were analysed.
Results between the two groups were compared by the Mann-Whitney U test. Urinary excretion of 5-hydroxyindole acetate was significantly greater in the patients with pregnancy induced hypertension than in the controls (table) . The difference was most marked for absolute concentrations, but was also apparent for excretion rate and concentration in relation to creatinine. There was no significant difference between the proteinuric hypertensive patients and the nonproteinuric hypertensive patients when comparing the 24 hour total urinary output of 5-hydroxyindole acetate or the ,umol/g of creatinine ratio.
Comment
Serotonin is a neurotransmitter and is also found in platelets, being released into the circulation during the platelet release reaction. It is extensively metabolised, 5-hydroxyindole acetic acid being the major metabolite. We have found substantially more 5-hydroxyindole acetate in the urine of women with pregnancy induced hypertension than in normotensive controls of similar gestation. A possible contributory factor to this could be related to the significant increase in embolic trophoblastic fragments found in the venous circulation of women with pregnancy induced hypertension compared with non-hypertensive controls.5 The trophoblastic fragments could attract platelets which in turn could release platelet serotonin. This trophoblastic factor is unique to pregnancy.
It is likely that the increased urinary excretion of 5-hydroxyindole acetate reflects increased circulating concentrations of serotonin, possibly related to trophoblastic fragmentation, which is significantly increased in women with pregnancy induced hypertension. Though this assumption contrasts with an earlier report,2 it is doubtful if the methodologies used in previous studies were of sufficient sensitivity. We would also propose that the increased circulating serotonin is derived from platelets which have undergone aggregation as part of the pre-eclamptic process. Our observations were made when hypertension was already established and we cannot therefore draw inferences about the possible contribution of serotonin to the initiation of the pre-eclamptic process. However, we suggest that increased circulating concentrations of serotonin could contribute to at least some of the features of pre-eclampsia or eclampsia. In particular, serotonin alone or in combination with other vasoconstrictor agents could contribute to the cerebral vasospasm which seems to be a feature of eclampia.4
